106

Posts By: Hugrún Kristjánsdóttir

Sigurður Ólafsson, Director of Hepatology

40 ára afmælisráðstefna SÁÁ: Treatment as prevention for hepatitis C (TraP HepC):  A nationwide elimination program in Iceland Sigurður Ólafsson, MD, FACP, Director of Hepatology, Division of Gastroenterology, Department of Medicine Landspitali University Hospital Abstract Hepatitis C virus (HCV) infection is one of the leading causes of cirrhosis and hepatocellular carcinoma worldwide. Injection drug use  is …Read more »

Erna Milunka Kojic, Professor at Division of Infectious Diseases

Erindi Ernu Milunka Kojic MD, professor at Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings

Judith A. Aberg, Professor of Medicine

40 ára afmælisráðstefna SÁÁ: A Structural Intervention to Improve Substance Abuse Diagnosis and Treatment Practices in HIV Clinic Settings. Treatment Adherence through the Advanced Use of Technology, preliminary findings Judith A. Aberg, MD, FIDSA, FACP, Professor of Medicine, Chief, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai Abstract: Despite treatment advances in HIV with aggressive treatment …Read more »

Þórólfur Guðnason, Chief Epidemiologist

Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health

Frank Vocci, Pres., Friends Research Institude

40 ára afmælisráðstefna SÁÁ: New approaches to developing medications for helping smokers quit Frank J. Vocci, PhD, President, Friends Research Institute Abstract Tobacco smoking is the leading cause of preventable death in many developed countries.  Nicotine replacement therapy (NRT) medications can double an individual’s chances of quitting but relapse is frequent. The majority of NRT …Read more »

Thorgeir Thorgeirsson, Phd, Decode Genetics

Erindi Thorgeirs Thorgeirssonar, PhD, Decode Genetics Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned?

Kári Stefánsson, MD, Decode Genetics

40 ára afmælisráðstefna SÁÁ: Genes, brain and behavior. The Decode SÁÁ research collaboration: what have we learned? Kári Stefánsson, MD, Decode Genetics Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors …Read more »

Panel discussion: Cannabis

Panel discussion: Cannabis Gerður Aaagot MD general practitioner, Rafn Magnús Jónsson, Project Manager at the Directorate of Health, politicians and policy makers and other interested parties.

Þórarinn Tyrfingsson MD, past Medical Director at SÁÁ

Erindi Þórarins Tyrfingssonar MD, past Medical Director at SÁÁ Cannabis addiction in Iceland